Cargando…
Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
BACKGROUND: Carvedilol (CVD) is used for the treatment of essential hypertension, heart failure, and systolic dysfunction after myocardial infarction. Due to its lower aqueous solubility and extensive first-pass metabolism, the absolute bioavailability of CVD does not exceed 30%. To overcome these d...
Autores principales: | Aljimaee, Yazeed HM, El-Helw, Abdel-Rahim M, Ahmed, Osama AA, El-Say, Khalid M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357615/ https://www.ncbi.nlm.nih.gov/pubmed/25834396 http://dx.doi.org/10.2147/DDDT.S80294 |
Ejemplares similares
-
Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits
por: El-Say, Khalid Mohamed, et al.
Publicado: (2018) -
Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects
por: Teng, Renli, et al.
Publicado: (2017) -
Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022) -
Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023) -
Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation
por: Ahmed, Tarek A, et al.
Publicado: (2016)